Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade

American Journal of Clinical Pathology

Volumn 106, Issue 1, 1996, Pages 52-56

  Tenti, Patrizia ^a,d   Romagnoli, Solange ^a   Silini, Enrico ^a   Zappatore, Rita ^a   Spinillo, Arsenio ^b   Giunta, Paolo ^a   Cappellini, Anna ^c   Vesentini, Nicoletta ^a   Zara, Carlo ^b   Carnevali, Luciano ^a  

^a Dept of Hum and Hered Pathology   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d Pathologic Anatomy   (Italy)

Author keywords

Adenocarcinoma; Cervix; HPV infection

Indexed keywords

ARTICLE; CANCER GRADING; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; WART VIRUS;

EID: 8944248815     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.1.52     Document Type: Article

References (30)

1. Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag, 1994, pp 300-309.
2. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-46.
3. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
4. Yoshikawa H, Matsukura T, Yamamoto E. Occurrence of human papillomavirus type 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas. Jpn J Cancer Res 1985;76:667-671.
5. Smotkin D, Berek JS, Fu YS. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol 1986;68:241-244.
6. Lorincz AT, Temple GF, Kurman RJ, Bennet Jenson A, Lancaster WD. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Nat Cancer Inst 1987;79:671-677.
7. Tase T, Okagaki T, Clark BA, Manias DA, Ostrow RS, Twiggs LB. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: A study by in situ DNA hybridization. Cancer Res 1988;48:993-998.
8. Wilczynski SP, Walker J, Liao SY, Bergen S, Berman M. Adenocarcinoma of the cervix associated with human papillomavirus. Cancer 1988;62:1331-1336.
9. Bjersing L, Rogo K, Evander M, Gerdes U, Stendahl U, Wadell G. HPV 18 and cervical adenocarcinomas. Anticancer Res 1991;11:123-128
10. Leminen A, Paavonen J, Vesterinen E, Wahlstrom T, Rantala I, Lehtinen M. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 1991;95:647-652.
11. Cooper K, Herrington CS, Lo ESF, Evans MF, McGee JO'D. Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma. J Clin Pathol 1992;45:382-384.
12. Hording U, Teglbjærg CS, Visfeldt J, Bock JE. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Gynecol Oncol 1992;46:313-316.
13. Stoler M, Greer C, Shick E, et al. The association and type distribution of HPVs in adenocarcinoma of the uterine cervix. Mod Pathol 1992;5:69A.
14. Johnson TL, Kim W, Plieth A, Sarkar FH. Detection of HPV 16/ 18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology. Mod Pathol 1992;5:35-40.
15. Alejo M, Macedo I, Guiu XM, Prat J. Adenocarcinoma in situ of the uterine cervix: Clinicopathological study of nine cases with detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1993;12:219-223.
16. Lee KR, Howard P, Heintz NH, Collins CC. Low prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma in situ, invasive adenocarcinoma, and glandular dysplasia by polymerase chain reaction. Mod Pathol 1993;6:433-437.
17. Samaratunga H, Cox N, Wright RG. Human papillomavirus DNA in glandular lesions of the uterine cervix. J Clin Pathol 1993;46: 718-721.
18. Milde-Langosh K, Schreiber C, Becker G, Loning T, Stegner HE. Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol 1993;24:590-594.
19. Duggan MA, Benoit JL, McGregor SE, Nation JG. Inoue M, Stuart GCE. The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization. Hum Pathol 1993;24:121-125.
20. Duggan MA, Mc Gregor SE, Benoit JL, Inoue M, Nation J,Stuart GCE. The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis. Hum Pathol 1995;26:319-325.
21. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23:117-128.
22. Sun Q, Tsutsumi K, Kelleher MB, Pater A, Pater MM. Squamous metaplasia of normal and carcinoma in situ of HPV 16 immorshy; talized human endocervical cells. Cancer Res 1992;52:4254-4260.
23. FIGO stages: 1988 revision. Gynecol Oncol 1989;35:125-127.
24. Tenti P, Romagnoli S, Silini E. et al. Analysis and clinical implications of K-ras gene mutations and infection with HPV types 16 and 18 in primary adenocarcinoma of the uterine cervix. Int J Cancer 1995;64:9-13.
25. Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital papillomavirus: Cancer cell 7. In: Furth M, Greaves M, eds. Molecular Diagnostics of Human Cancer. Cold Spring, NY: Cold Spring Harbor Press. 1989, pp 209-214.
26. King LA, Tase T, Twiggs LB. Prognostic significance of the presence of human papillomavirus type in cervical cancer. Cancer 1989;63:897-900.
27. Barnes W, Delgado G, Kurman RJ. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 1988;29:267-273.
28. Stoler MH, Steinetz C, Shick K, Goodrich K, Abdul-Karim F. The association of human papillomavirus with non endocervical types of cervical adenocarcinoma has carcinogenic implications. Lab Invest 1994;70:96A (Abstr).
29. Noda K, Kimura K, Ikeda M, Teshima K. Studies on the histogenesis of cervical adenocarcinoma. Int J Gynecol Pathol 1983;1: 336-346.
30. Tenti P, Pavanello S, Romagnoli S, et al. p53 mutations in cervical adenocarcinoma. Lab Invest 1995;72:98A (Abstr).